156 related articles for article (PubMed ID: 3895033)
1. Parkinson's disease: a comparison of mesulergine and bromocriptine.
Burton K; Larsen TA; Robinson RG; Bratty PJ; Martin WR; Schulzer M; Calne DB
Neurology; 1985 Aug; 35(8):1205-8. PubMed ID: 3895033
[TBL] [Abstract][Full Text] [Related]
2. Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism.
Baas H; Schneider E; Fischer PA; Japp G
J Neural Transm; 1985; 64(1):45-54. PubMed ID: 4067602
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
Godwin-Austen RB; Smith NJ
J Neurol Neurosurg Psychiatry; 1977 May; 40(5):479-82. PubMed ID: 330825
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.
Jellinger K
J Neurol; 1982; 227(2):75-88. PubMed ID: 6180142
[TBL] [Abstract][Full Text] [Related]
5. Mesulergine (CU 32-085) in the treatment of Parkinson's disease.
Rascol A; Montastruc JL; Rascol O; Senard JM
Clin Neuropharmacol; 1986; 9(2):146-52. PubMed ID: 3708600
[TBL] [Abstract][Full Text] [Related]
6. Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study.
LeWitt PA; Gopinathan G; Ward CD; Sanes JN; Dambrosia JM; Durso R; Calne DB
Neurology; 1982 Jan; 32(1):69-72. PubMed ID: 7033825
[TBL] [Abstract][Full Text] [Related]
7. Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
Goetz CG; Tanner CM; Glantz RH; Klawans HL
Neurology; 1985 May; 35(5):749-51. PubMed ID: 3990974
[TBL] [Abstract][Full Text] [Related]
8. Double-blind comparison of cabergoline and bromocriptine in Parkinson's disease patients with motor fluctuations.
Inzelberg R; Nisipeanu P; Rabey JM; Orlov E; Catz T; Kippervasser S; Schechtman E; Korczyn AD
Neurology; 1996 Sep; 47(3):785-8. PubMed ID: 8797480
[TBL] [Abstract][Full Text] [Related]
9. Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
Kartzinel R; Shoulson I; Calne DB
Neurology; 1976 Jun; 26(6 PT 1):511-3. PubMed ID: 778655
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Parkinson's disease with dopamine agonists: a review.
Lieberman A; Neophytides A; Kupersmith M; Casson I; Durso R; Foo SH; Khayali M; Tartaro T; Goldstein M
Am J Med Sci; 1979; 278(1):65-76. PubMed ID: 39452
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action and tolerance of mesulergine.
Lamberts SW; Klÿn JG; Oosterom R
Clin Pharmacol Ther; 1984 Nov; 36(5):620-7. PubMed ID: 6488683
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa.
Marsden CD
Drugs; 1998; 55 Suppl 1():17-22. PubMed ID: 9483166
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Parkinson's disease with bromocriptine].
Castaigne P; Laplane D; Bousser MG; Bories F
Nouv Presse Med; 1976 Apr; 6(17):1482. PubMed ID: 1037400
[No Abstract] [Full Text] [Related]
14. Treatment of parkinson's disease with bromocriptine.
Lieberman A; Kupersmith M; Estey E; Goldstein M
N Engl J Med; 1976 Dec; 295(25):1400-4. PubMed ID: 989885
[TBL] [Abstract][Full Text] [Related]
15. Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies.
LeWitt PA; Burns RS; Calne DB
Adv Neurol; 1983; 37():131-40. PubMed ID: 6344586
[TBL] [Abstract][Full Text] [Related]
16. Three-year observation of mesulergine (CU 32-085) in advanced and newly treated parkinsonism.
Schneider E; Baas H; Fischer PA; Japp G
J Neurol; 1985; 232(1):24-8. PubMed ID: 3998771
[TBL] [Abstract][Full Text] [Related]
17. Placebo-controlled study of mesulergine in Parkinson's disease.
Jankovic J; Orman J; Jansson B
Neurology; 1985 Feb; 35(2):161-5. PubMed ID: 3881692
[TBL] [Abstract][Full Text] [Related]
18. An ergot derivative in the treatment of Parkinson's disease.
Calne DB; Shoulson I; Kartzinel R
Postgrad Med J; 1976; 52suppl 1():81-5. PubMed ID: 183198
[No Abstract] [Full Text] [Related]
19. Mesulergine (CU32-085) in the treatment of Parkinson's disease.
Pfeiffer RF; Wilken K; Glaeske C
Ann Neurol; 1985 Apr; 17(4):334-6. PubMed ID: 3890700
[TBL] [Abstract][Full Text] [Related]
20. Mesulergine in early Parkinson's disease: a double blind controlled trial.
Dupont E; Mikkelsen B; Jakobsen J
J Neurol Neurosurg Psychiatry; 1986 Apr; 49(4):390-5. PubMed ID: 3517235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
